Enrich and detect CTCs of prostate cancer from blood

Enrich and detect CTCs of prostate cancer from blood

Anatomy - Pathology

March 01, 2017

Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. In prostate cancer, the expression of three tumor-associated transcripts, prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), are often altered and used as biomarkers.

In addition, cell surface PSMA presents a unique target for treatment of patients early in their development of prostatic metastases.
How can you detect PSMA, PSA and EGFR in prostate cancer from blood? Learn more

 

 

BRCA Tumor MASTR Plus Product launch

BRCA Tumor MASTR Plus Product launch

Anatomy - Pathology

Multiplicom is pleased to announce the release of the BRCA Tumor MASTR Plus molecular assay, research use only, for identification of SNVs in the coding region of BRCA1 and BRCA2 in various types of solid tumors.

June 17, 2015 More +
IDEXX Enterolert-DW Obtains the First AFNOR NF VALIDATION for Detection of Enterococci in Drinking Water

IDEXX Enterolert-DW Obtains the First AFNOR NF VALIDATION for Detection of Enterococci in Drinking Water

Anatomy - Pathology

IDEXX announces that the Association Française de Normalisation (AFNOR) has just granted NF Validation to the method Enterolert®-DW and Quanti-Tray® for the detection of enterococci in drinking water (Certificate Number IDX 33/03-10/13). This new validation makes Enterolert-DW the first and only method validated by AFNOR for the detection of enterococci bacteria in drinking water.

November 01, 2013 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us